innovative platform technology

Innovative Technology Platform

Entera's innovative technology enables oral drug delivery of large molecules

27163516 pills

Pipeline of Drug Development

Entera conducts clinical trials of three oral drugs based on a proven active compound

27163516 brain green

Experienced Management Team

The managers of Entera have more than 50 years of experience in drug development

January 22, 2014 – Entera has submitted to the U.S. Food and Drug Administration (FDA) an application for recognition as an orphan drug for the treatment of hypoparathyroidism with Entera’s oral PTH 1-34.